Cardiovascular Therapeutics / 2021 / Article / Tab 4 / Research Article
Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes Table 4 Regression and partial correlation coefficients between examined variables and PCSK9 in patients with type 2 diabetes mellitus, after adjustment for age and sex.
Parameter Diabetes duration (yrs) 114 -1.019 -0.07 0.13 0.4594 HbA1c (%) 87 -9.608 -0.21 0.03 0.0533 Waist circumference (cm) 113 0.923 0.12 0.04 0.2125 WHR 112 94.642 0.06 0.37 0.5557 BMI (kg/m2 ) 116 2.705 0.15 0.04 0.1061 SBP (mmHg) 115 1.028 0.17 0.15 0.0674 DBP (mmHg) 115 1.781 0.20 0.03 0.0342 TC (mmol/l) 106 43.398 0.56 0.07 <0.001 TG (mmol/l) 106 35.796 0.43 0.05 <0.001 HDL-C (mmol/l) 106 14.826 0.04 0.06 0.6688 LDL-C (mmol/l) 98 38.147 0.45 0.08 <0.001 Glucose (mmol/l) 91 0.687 0.02 0.01 0.8747 Creatinine (mmol/l) 108 0.302 0.07 0.15 0.4685 Uric acid (μ mol/l) 103 0.173 0.16 0.05 0.1217 Bilirubin (μ g/dl) 95 -1.814 -0.08 0.06 0.4235 CK-18 (U/l) 116 0.011 0.06 0.10 0.5384 PTX3 (ng/ml) 116 16.033 0.46 0.05 <0.001 apo B48 (ng/ml) 115 0.008 0.31 0.02 0.0008 apo B100 (mg/dl) 116 1.681 0.43 0.01 <0.001 apo A1 (mg/dl) 116 1.623 0.46 0.00 <0.001 apo C3 (μ g/dl) 115 0.260 0.30 0.06 0.0013 sLDLr (ng/ml) 116 -2.478 -0.79 0.04 <0.001 FLI 100 0.751 0.16 0.03 0.1179 AST (U/l) 109 -0.153 -0.04 0.11 0.6539 ALT (U/l) 110 -0.202 -0.07 0.17 0.4601 GGTP (U/l) 106 -0.033 -0.01 0.10 0.9027
: partial regression coefficient;
: partial correlation coefficient;
: partial determination coefficient.